86
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.012
Exchange
XHKG - Hong Kong Exchange
-0.0028 B
Last period CFO ,CNY
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Huakang Biomedical
Company Analysis
8622.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
8622.HK financial analysis by Eyestock methodology
Valuation
8622.HK valuation using historical relative method
Statements
8622.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
8622.HK dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Huakang Biomedical`s CFO for the period ended 2024-06-30 is -0.0028 B CNY
